Table 2.
Secondary transmission in the 2009 and 2012 outbreaks
| 2009 outbreak [12] | 2012 outbreak [11] | |
|---|---|---|
| Included primary cases; clinical case definition, n | Not included | 24 |
| Included primary cases; laboratory-confirmed, n | 8 | 9 |
| Primary cases confirmed by IFAT/PCR, n/n | 8/8 | 9/6 |
| Primary cases subtyped as IIaA19G1R1, n | 7 | 4 |
| Household contacts examined*, n | 23 | 83 |
| Clinically defined secondary cases, n (%) | 2 (9%) | 7 (8%) |
| Secondary cases confirmed by IFAT (%)/PCR, n/n | 4 (17%)/1 | 0 (0%)/0 |
| Secondary cases subtyped as IIaA19G1R1, n | 1 | 0 |
IFAT, Immunofluorescence antibody test; PCR, polymerase chain reaction.
All household contacts in 2012; only household contacts of laboratory-confirmed primary cases in 2009.